Clinical Trials Browser

Completed × Carcinoma, Renal Cell × Erlotinib Hydrochloride × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT01688973 2019-01-03

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

55 enrolled 16 charts

Carcinoma, Renal Cell

NCT00425386 2017-05-03

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Completed

60 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

GastrointestinalGenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors

NCT00101348 2014-06-11

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Phase 1/2 Completed

CNSGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00081614 2014-05-16

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma

Phase 2 Completed

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00353301 2014-04-14

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

Phase 2 Completed

25 enrolled 9 charts

Carcinoma, Renal Cell

NCT00045487 2014-01-27

OSI-774

Phase 2 Completed

41 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00060307 2013-02-28

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00193258 2013-01-31

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Phase 1/2 Completed

94 enrolled 7 charts

Carcinoma, Renal Cell